跳至主要内容
临床试验/IRCT20170215032587N2
IRCT20170215032587N2已完成未知

Effect of Phenobarbital to Reduce Newborn Readmissions for Hyperbilirubinemia

Ghoum University of Medical Sciences0 个研究点目标入组 142 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
142

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 day 至 10 days(—)
性别
All

入选标准

  • Have a major risk factors for development of severe hyperbilirubinemia
  • Hospitalized because of hyperbilirubinemia in the first 10 days of birth

排除标准

  • Major congenital malformations
  • Gestational age <35 weeks
  • Weight <2500 g at birth
  • History of blood transfusion
  • History of IVIG administration
  • History of maternal use of phenobarbital in the last month of pregnancy
  • Whose parents refused to give consent

研究者

发起方
Ghoum University of Medical Sciences

相似试验